医知素材库-为医护人员提供品管圈护理查房PPT模版总结教育等个人教学笔记!
      医护资料汇总: 62127
更新:

张张在09:09:22购买了:一年会员

桃儿在16:46:59购买了:三年会员

小米呀在15:10:44购买了:三身会员

欣欣在15:44:00购买了:一年会员

歌尔飞在21:52:57购买了:三身会员

杨亚辉在10:15:27购买了:三年会员

匿名用户在16:08:05购买了:一身会员

最新资料

最新发布第737页
2023NICE技术鉴定指导意见:治疗由结节性硬化症引起的癫痫发作的大麻二酚[TA873]-医知素材库

2023NICE技术鉴定指导意见:治疗由结节性硬化症引起的癫痫发作的大麻二酚[TA873]

NENatonalinsuitute forHealth and Care ExcellenceNICE贝guidanceCannabidiol for treatingseizures caused bytuberous sclerosis complexTechnology appraisal guidancePublished:1 March 202...
2023NICE介入手术指南:经皮腔内肾交感神经去神经支配治疗难治性高血压[IPG754]-医知素材库

2023NICE介入手术指南:经皮腔内肾交感神经去神经支配治疗难治性高血压[IPG754]

NICENational Institute forHealth and Care ExcellenceNICE贝guidancePercutaneous transluminal renalsympathetic denervation forresistant hypertensionInterventional procedures guidance...
2023NICE技术鉴定指导意见:他法西单抗联合来那度胺治疗复发或难治性弥漫性大B细胞淋巴瘤[TA883]-医知素材库

2023NICE技术鉴定指导意见:他法西单抗联合来那度胺治疗复发或难治性弥漫性大B细胞淋巴瘤[TA883]

NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceTafasitamab withlenalidomide for treatingrelapsed or refractorydiffuse large B-celllymphomaTechnology appraisal guidanc...
2023NICE技术鉴定指导意见:伊沙佐米联合来那度胺和地塞米松治疗复发或难治性多发性骨髓瘤[TA870]-医知素材库

2023NICE技术鉴定指导意见:伊沙佐米联合来那度胺和地塞米松治疗复发或难治性多发性骨髓瘤[TA870]

NENatonalinsuitute forHealth and Care ExcellenceNICE贝guidanceIxazomib with lenalidomideand dexamethasone fortreating relapsed orrefractory multiplemyelomaTechnology appraisal guid...
2023NICE技术鉴定指导意见:瑞培替尼治疗3次或以上治疗后的晚期胃肠道间质瘤[TA881]-医知素材库

2023NICE技术鉴定指导意见:瑞培替尼治疗3次或以上治疗后的晚期胃肠道间质瘤[TA881]

NCENaiional nstitute forHealth and Care ExcellenceNICE贝guidanceRipretinib for treatingadvanced gastrointestinalstromal tumour after 3 ormore treatmentsTechnology appraisal guidanc...
2023NICE技术鉴定指导意见:瑞戈非尼用于既往治疗过的转移性结直肠癌[TA866]-医知素材库

2023NICE技术鉴定指导意见:瑞戈非尼用于既往治疗过的转移性结直肠癌[TA866]

NICENational Institute forHealth and Care ExcellenceNICE贝guidanceRegorafenib for previouslytreated metastaticcolorectal cancerTechnology appraisal guidancePublished:8 February 202...
2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]-医知素材库

2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]

NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceTrastuzumab deruxtecanfor treating HER2-positiveunresectable or metastaticbreast cancer after 1 ormore anti-HER2treatme...
2023NICE技术鉴定指导意见:泊洛妥珠单抗-维布妥昔单抗联合治疗未经治疗的弥漫性大B细胞淋巴瘤[TA874]-医知素材库

2023NICE技术鉴定指导意见:泊洛妥珠单抗-维布妥昔单抗联合治疗未经治疗的弥漫性大B细胞淋巴瘤[TA874]

NENatonalinsutute forHealth and Care ExcellenceNICE贝guidancePolatuzumab vedotin incombination for untreateddiffuse large B-celllymphomaTechnology appraisal guidancePublished:1 Mar...
2023NICE技术鉴定指导意见:纳武单抗联合化疗用于可切除非小细胞肺癌的新辅助治疗[TA876]-医知素材库

2023NICE技术鉴定指导意见:纳武单抗联合化疗用于可切除非小细胞肺癌的新辅助治疗[TA876]

NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceNivolumab withchemotherapy forneoadjuvant treatment ofresectable non-small-celllung cancerTechnology appraisal guidance...
2023NICE技术鉴定指导意见:派姆单抗联合化疗联合或不联合贝伐单抗治疗持续性、复发性或转移性宫颈癌[TA885]-医知素材库

2023NICE技术鉴定指导意见:派姆单抗联合化疗联合或不联合贝伐单抗治疗持续性、复发性或转移性宫颈癌[TA885]

NENatonalinsutute forHealth and Care ExcellenceNICE贝guidancePembrolizumab pluschemotherapy with orwithout bevacizumab forpersistent,recurrent ormetastatic cervical cancerTechnolog...